CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
132 hedge funds and large institutions have $623M invested in Cymabay Therapeutics in 2018 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
17% less capital invested
Capital invested by funds: $755M → $623M (-$132M)
Holders
132
Holding in Top 10
5
Calls
$766K
Puts
$669K
Top Buyers
| 1 | +$8.66M | |
| 2 | +$6.81M | |
| 3 | +$5.41M | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
+$5.15M |
| 5 |
BlackRock
New York
|
+$4.26M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$10.6M | |
| 3 | -$8.03M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.54M |
| 5 |
OA
Omega Advisors
New York
|
-$5.06M |